Center of Biomedical Research, Faculty of Medicine, Universidad Diego Portales, Santiago, Chile.
Alcohol Clin Exp Res. 2011 Apr;35(4):606-12. doi: 10.1111/j.1530-0277.2011.01439.x. Epub 2011 Feb 17.
While the molecular entity responsible for the rewarding effects of virtually all drugs of abuse is known, that for ethanol remains uncertain. Some lines of evidence suggest that the rewarding effects of alcohol are mediated not by ethanol per se but by acetaldehyde generated by catalase in the brain. However, the lack of specific inhibitors of catalase has not allowed strong conclusions to be drawn about its role on the rewarding properties of ethanol. The present studies determined the effect on voluntary alcohol consumption of two gene vectors, one designed to inhibit catalase synthesis and one designed to synthesize alcohol dehydrogenase (ADH), to respectively inhibit or increase brain acetaldehyde synthesis.
The lentiviral vectors, which incorporate the genes they carry into the cell genome, were (i) one encoding a shRNA anticatalase synthesis and (ii) one encoding alcohol dehydrogenase (rADH1). These were stereotaxically microinjected into the brain ventral tegmental area (VTA) of Wistar-derived rats bred for generations for their high alcohol preference (UChB), which were allowed access to an ethanol solution and water.
Microinjection into the VTA of the lentiviral vector encoding the anticatalase shRNA virtually abolished (-94% p < 0.001) the voluntary consumption of alcohol by the rats. Conversely, injection into the VTA of the lentiviral vector coding for ADH greatly stimulated (2 to 3 fold p < 0.001) their voluntary ethanol consumption.
The study strongly suggests that to generate reward and reinforcement, ethanol must be metabolized into acetaldehyde in the brain. Data suggest novel targets for interventions aimed at reducing chronic alcohol intake.
虽然几乎所有滥用药物的奖赏效应的分子实体都已明确,但乙醇的奖赏效应的分子实体仍不确定。一些证据表明,酒精的奖赏效应不是由乙醇本身介导的,而是由大脑中的过氧化氢酶生成的乙醛介导的。然而,由于缺乏过氧化氢酶的特异性抑制剂,因此无法对其在乙醇奖赏特性中的作用得出明确的结论。本研究通过两种基因载体,分别设计用于抑制过氧化氢酶合成和合成醇脱氢酶(ADH),来确定它们对自愿饮酒的影响,以分别抑制或增加大脑乙醛的合成。
将携带其基因的慢病毒载体(i)一种编码抗过氧化氢酶合成的 shRNA 和(ii)一种编码醇脱氢酶(rADH1),立体定向地微注射到 Wistar 衍生的大鼠腹侧被盖区(VTA)。这些大鼠经过几代的选育,具有高酒精偏好(UChB),可以接触到乙醇溶液和水。
将编码抗过氧化氢酶 shRNA 的慢病毒载体微注射到 VTA 中,几乎完全消除了(-94%,p < 0.001)大鼠对酒精的自愿消耗。相反,将编码 ADH 的慢病毒载体注射到 VTA 中,大大刺激了(2 到 3 倍,p < 0.001)它们对乙醇的自愿消耗。
该研究强烈表明,为了产生奖赏和强化,乙醇必须在大脑中代谢为乙醛。数据为旨在减少慢性饮酒的干预措施提供了新的靶点。